Jiangsu Lintex Advanced Materials
920106
Beijing Chieftain Control Technology Group
300430
Jiangsu Apon Medical Technology
300753
Fujian Zitian Media Technology
300280
SigmaStar Technology
301536
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total operating revenue | 14.73%319.92M | -3.85%200.2M | -35.70%72.45M | -33.24%412.18M | -28.26%278.86M | 107.33%208.21M | 194.97%112.66M | 30.53%617.41M | 35.77%388.71M | -35.66%100.42M |
Operating revenue | 14.73%319.92M | -3.85%200.2M | -35.70%72.45M | -33.24%412.18M | -28.26%278.86M | 107.33%208.21M | 194.97%112.66M | 30.53%617.41M | 35.77%388.71M | -35.66%100.42M |
Other operating revenue | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 |
Interest income | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | --0 |
Commission income | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | --0 |
Premiums earned | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | --0 |
Total operating cost | 4.61%322.94M | -5.72%203.48M | -28.43%83.21M | -25.04%441.28M | -15.88%308.72M | 52.07%215.83M | 76.69%116.27M | 26.78%588.72M | 23.08%366.98M | -19.02%141.93M |
Operating cost | 4.27%164.17M | -12.38%103.82M | -46.96%35.55M | -41.59%213.92M | -30.21%157.45M | 142.66%118.49M | 247.81%67.02M | 44.34%366.25M | 46.53%225.59M | -41.21%48.83M |
Operating tax surcharges | -49.37%1.77M | -37.70%909.12K | -76.21%213.51K | 163.79%5.92M | 299.75%3.49M | 94.90%1.46M | 55.71%897.29K | -13.51%2.24M | -40.29%873.23K | -13.67%748.67K |
Operating expense | 4.10%50.36M | -6.40%31.35M | -5.50%14.31M | -4.94%70.68M | -2.10%48.38M | 7.74%33.49M | 5.67%15.15M | 14.45%74.36M | 16.90%49.42M | 16.52%31.09M |
Administration expense | -0.31%39.55M | -3.65%24.87M | -3.75%10.98M | -2.26%57.47M | -2.66%39.68M | -12.12%25.82M | -4.29%11.41M | 6.86%58.8M | 3.91%40.76M | 20.61%29.38M |
Financial expense | 4.66%-4.53M | -12.16%-5.67M | -460.98%-1.37M | 39.15%-5.91M | 61.13%-4.75M | 38.59%-5.06M | -16.69%379.72K | -637.98%-9.71M | -4,099.61%-12.22M | -986.55%-8.23M |
-Interest expense (Financial expense) | -37.18%465.54K | -41.73%330.61K | -39.82%178.62K | -20.76%931.81K | -14.36%741.08K | 4.88%567.37K | 52.77%296.83K | 96.23%1.18M | 209.51%865.38K | 93.49%540.98K |
-Interest Income (Financial expense) | -166.64%-7.62M | -134.04%-5.64M | -39.77%-1.63M | -58.80%-5.47M | 21.80%-2.86M | -47.99%-2.41M | -79.75%-1.17M | 5.63%-3.44M | -81.09%-3.66M | -1.63%-1.63M |
Research and development | 11.09%71.62M | 15.78%48.19M | 9.85%23.53M | 2.50%99.2M | 3.07%64.47M | 3.75%41.63M | 11.28%21.42M | 12.23%96.78M | 2.67%62.55M | 1.90%40.12M |
Credit Impairment Loss | -234.79%-2.77M | -122.28%-1.22M | -39.50%1.35M | 126.59%1.58M | 122.47%2.06M | 87.69%-549.58K | 79.20%2.24M | 59.00%-5.92M | -2.85%-9.15M | 53.37%-4.46M |
Asset Impairment Loss | -123.86%-125.07K | -86.84%32.75K | -21.25%91.25K | -139.35%-17.79M | 182.70%524.22K | 282.20%248.86K | -59.84%115.88K | -457.59%-7.43M | 56.24%-633.91K | 81.20%-136.59K |
Other net revenue | -31.57%13.65M | -6.86%10.87M | 14.50%8.87M | -15.34%4.92M | 153.31%19.95M | 28.85%11.67M | -26.79%7.75M | 485.24%5.81M | 511.15%7.88M | 591.07%9.06M |
Fair value change income | ---83.7K | --35.7K | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --0 |
Invest income | 6.67%5.99M | 32.87%5.04M | 42.11%3.62M | 102.49%7.09M | 486.02%5.62M | 641.34%3.79M | 392.49%2.55M | 185.37%3.5M | 161.87%958.57K | 174.62%511.48K |
Net open hedge income | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | --0 |
-Including: Investment income associates | 1,131.72%1.2M | 2,157.75%1.31M | -40.74%-88.86K | 92.77%-88.86K | 91.41%-116.27K | 95.94%-63.61K | 92.75%-63.13K | 73.23%-1.23M | 33.23%-1.35M | -110.75%-1.57M |
Exchange income | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | --0 |
Asset deal income | --885.88K | ---- | --0 | --0 | --0 | ---- | --0 | --262.52K | --262.52K | --262.52K |
Other revenue | -17.02%9.76M | -14.61%6.99M | 33.66%3.81M | -8.81%14.05M | -28.47%11.76M | -36.50%8.18M | -70.50%2.85M | -15.01%15.41M | 24.71%16.44M | 40.98%12.89M |
Operating profit | 207.32%10.63M | 87.46%7.6M | -145.80%-1.9M | -170.06%-24.18M | -133.46%-9.91M | 112.49%4.05M | 124.32%4.14M | 258.35%34.51M | 380.53%29.61M | -54.36%-32.45M |
Add:Non operating Income | 370.44%134.61K | -29.25%13.78K | --0 | -33.03%33.4K | -39.92%28.61K | -53.37%19.48K | -77.82%8.2K | 5.40%49.88K | 975.87%47.62K | --41.77K |
Less:Non operating expense | 1,093.23%49.14K | 263.51%3.28K | -54.18%400 | -71.27%36.15K | -66.97%4.12K | -61.70%902.38 | -73.26%873 | 217.10%125.82K | 40,414.75%12.47K | --2.36K |
Total profit | 208.45%10.72M | 86.87%7.61M | -145.73%-1.9M | -170.23%-24.18M | -133.34%-9.88M | 112.56%4.07M | 124.41%4.15M | 257.28%34.43M | 380.98%29.64M | -54.17%-32.41M |
Less:Income tax cost | -105.49%-21.98K | 144.62%91.64K | -17.28%371.72K | 70.77%-630.96K | 122.73%400.18K | 78.85%-205.37K | 122.37%449.39K | -325.01%-2.16M | -226.03%-1.76M | -100.26%-971.17K |
Net profit | 204.45%10.74M | 75.75%7.52M | -161.33%-2.27M | -164.36%-23.55M | -132.74%-10.28M | 113.60%4.28M | 121.51%3.7M | 260.67%36.59M | 413.73%31.4M | -53.08%-31.44M |
Net profit from continuing operation | 204.45%10.74M | 75.75%7.52M | -161.33%-2.27M | -164.36%-23.55M | -132.74%-10.28M | 113.60%4.28M | 121.51%3.7M | 260.67%36.59M | 413.73%31.4M | -53.08%-31.44M |
Net income from discontinuing operating | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | --0 | --0 |
Less:Minority Profit | ---2.53K | ---- | --0 | --0 | --0 | ---- | --0 | 65.54%-261.08K | 64.61%-254.04K | 69.41%-219.59K |
Net profit of parent company owners | 204.47%10.74M | 75.75%7.52M | -161.33%-2.27M | -163.90%-23.55M | -132.48%-10.28M | 113.70%4.28M | 121.68%3.7M | 238.00%36.85M | 440.70%31.66M | -57.52%-31.22M |
Earning per share | ||||||||||
Basic earning per share | 200.00%0.06 | 100.00%0.04 | -133.33%-0.01 | -165.00%-0.13 | -135.29%-0.06 | 109.09%0.02 | 123.87%0.03 | 150.00%0.2 | 350.00%0.17 | -51.62%-0.22 |
Diluted earning per share | 200.00%0.06 | 100.00%0.04 | -133.33%-0.01 | -165.00%-0.13 | -135.29%-0.06 | 109.09%0.02 | 123.87%0.03 | 150.00%0.2 | 350.00%0.17 | -51.62%-0.22 |
Other composite income | 519.62%27.11K | -2,975.59%-34.76K | 95.17%-380.91 | 46.44%-6.88K | 31.64%-6.46K | -117.24%-1.13K | -764.01%-7.89K | -280.99%-12.85K | -751.17%-9.45K | 86.76%6.56K |
Other composite income of parent company owners | 519.62%27.11K | -2,975.59%-34.76K | 95.17%-380.91 | 46.44%-6.88K | 31.64%-6.46K | -117.24%-1.13K | -764.01%-7.89K | -280.99%-12.85K | -751.17%-9.45K | 86.76%6.56K |
Other composite income of minority owners | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
Total composite income | 204.64%10.77M | 74.98%7.48M | -161.47%-2.27M | -164.40%-23.55M | -132.77%-10.29M | 113.60%4.28M | 121.47%3.69M | 260.29%36.58M | 413.68%31.39M | -53.07%-31.43M |
Total composite income of parent company owners | 204.67%10.77M | 74.98%7.48M | -161.47%-2.27M | -163.94%-23.55M | -132.51%-10.29M | 113.70%4.28M | 121.63%3.69M | 237.66%36.84M | 440.65%31.65M | -57.51%-31.21M |
Total composite income of minority owners | ---2.53K | ---- | --0 | --0 | ---- | ---- | --0 | 65.54%-261.08K | 64.61%-254.04K | 69.41%-219.59K |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.